THE CONFERENCE IS CONCLUDED. ON THE SITE IS AVAILABLE BROADCAST IN THE RECORD
«Innovations in internal medicine»
-
Room №1
-
Room №2
Programme
-
Hall №1
-
Hall №2
-
Hall №3
Opening of the Conference
Master class «COVID-19: do all questions have an answer?»
Moderators:
G.E. Gendlin, N.G. Poteshkina, A.V. Melekhov
- Heart failure in COVID-19: do all questions have an answer?
- N.G. Poteshkina
- Patients with COVID-19 at the hospital and post-hospital period – do they need a heart check-up?
- G.E. Gendlin
- Post-Covid syndrome
- A.V. Melekhov
Break
Special Session (60 minutes) «New molecules and new approaches in CHF therapy»
Moderator:
G.P. Arutyunov
Break
Symposium «COVID-19: The accumulated experience»
Moderator:
A.G. Arutyunov
- Two years of COVID-19, the experience of 7 countries
- E.I. Tarlovskaya
- Omicron: The differences in the clinical picture. Does the risk remain?
- A.G. Arutyunov
- Targeted therapy in the treatment of COVID-19 – data for 2022
- S.N. Avdeev
- Monoclonal antibodies in the treatment of COVID-19
- D.S. Fomina
Break
Symposium «Post-COVID: long-term changes»
Moderator:
A.G. Arutyunov
- Management strategies for patients with hypertension during the pandemic
- O.D. Ostroumova
- A patient after COVID-19 as a new risk category
- A.G. Arutyunov
- Antibiotic-associated colitis in Post-COVID
- N.V. Bakulina, O.I. Solovieva
- Rehabilitation after COVID-19. Experience of the Republic of Armenia
- Lamara Manukyan
Wrap up of the Conference
Broadcast in Hall №1
Opening of the Conference
Satellite Symposium «Innovations in intensification: LDL-C control in Russian realities»
(sponsored by Sanofi)
Moderator:
M.V. Ezhov
- Dyslipidemia 2022: key trends and innovative solutions
- M.V. Ezhov
- The role of general practitioner in lipid storage disease management in patients with high and very high CV risk
- A.G. Arutyunov
- New opportunities in lipid-lowering therapy intensification
- Yu.A. Karpov
- Opportunities in the routing organization and effective treatment in patients with ACS: the place of PCSK9i
- A.Yu. Lebedeva
Break
Satellite Symposium «The renaissance of the future: Long-awaited reality in treatment of CKD patients»
(sponsored by AstraZeneca)
Moderator:
A.G. Arutyunov
- A change navigator, focus on early diagnosis of patients with CKD
- T.V. Adasheva
- The birth of the future: DAPA-CKD as revolution of ideas in CKD patients management
- O.Yu. Sukhareva
- Caring for the heart: Findings from the DAPA-CKD trial in patients with cardiovascular diseases
- S.V. Villevalde
Break
Satellite Symposium «Type 2 diabetes and heart failure. How to sail between Scylla and Charybdis without a loss?»
(sponsored by Boehringer Ingelheim)
Moderator:
G.P. Arutyunov
- Heart failure with reduced ejection fraction – the importance of nephroprotective therapy
- M. Batyushin
- When do we start therapy for heart failure with SGLT2 inhibitors: inpatient or outpatient?
- G. Arutyunov
- Type 2 diabetes and heart failure. How to sail between Scylla and Charybdis without a loss?
- Yu.Sh. Khalimov
- Practical aspects of iSGLT2 use when administered without type 2 diabetes mellitus
- I.В. Zhirov
Break
Symposium «From atherosclerosis to CHF: what’s new in 2022»
Moderator:
O.N. Dzhioeva
- A patient with thrombosis: diversity of the problem and unity of solution
- O.N. Dzhioeva
- Oral GLP-1 receptor agonists: new perspectives
- Sarantis LIvadas (Athens)
- Therapy to prevent deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients with CHF (congestive heart failure) – new steps in 2022
- Akhmetzhan Sugraliev
Broadcast in Hall №1
Wrap up of the Conference
Broadcast in Hall №1
Opening of the Conference
Broadcast in Halls №1 and №2
Break
No broadcast
Break
No broadcast
Break
No broadcast
Broadcast in Hall №1
Wrap up of the Conference
